The Value of 320-Row Multidetector CT Bronchial Arteriography in Recurrent Hemoptysis after Failed Transcatheter Arterial Embolization

Zhao, Tian; Wang, Sini; Zheng, Lili; Jia, Zhongzhi; Yang, Yunjun; Wang, Weiping; Sun, Hao

doi:10.1016/j.jvir.2017.01.006

“…Among whom, there were 40 males (70.2%), and the mean SD age at admission was 54. 4 MDCT angiography and BAE procedure for detection of culprit arteries…”

Section: Baseline Characteristicsmentioning

confidence: 99%

“…To date, there have been many studies reporting that MDCT angiography before BAE plays a critical role in diagnosing both abnormal arteries and underlying lung diseases for hemoptysis [5][6][7][8][9][10][11]. Importantly, it is especially effective to identify origins and courses of ectopic BAs and NBSAs, which should be useful for the management of this disease [4,5,12,13].…”

Section: Introductionmentioning

confidence: 99%

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Le¹,

Le

²

,

Phạm

³

et al. 2020

Preprint

0

View full text Add to dashboard Cite

Background: Multidetector computed tomography (MDCT) angiography is an useful examination to detect the source of the bleeding in patients with hemoptysis. The aim of the study was to prospectively evaluate the role and clinical efficacy of MDCT angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence.Methods: It is a double-center study which included 57 hemoptysis patients undergoing MDCT angiography prior to BAE from August 2019 to July 2020. A prospective analysis of culprit arteries detected by MDCT angiography allowed an evaluation of the role of this technique. A follow-up was done to assess the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis.Results: The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 1.73. Among which, the average numbers of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 0.41 and 1.04 1.57, respectively. The immediate clinical success rate, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7%, 18.5%, 16.7%, respectively. Aspergilloma (HR = 6.63, 95% CI: 1.31-33.60, p = 0.022) was associated with an increase in the risk of early recurrence.Conclusions: MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.

show abstract

“…To date, there have been many studies reporting that multidetector computed tomography (MDCT) angiography before BAE plays a critical role in the diagnosis of abnormal arteries and the hemoptysis cause [9][10][11][12][13][14][15]. Importantly, it effectively identi es origins and courses of ectopic BAs and NBSAs, which should be useful for the management of this disease [8,9,16,17]. In addition, bronchoscopy has been also known as an important procedure in the work-up of hemoptysis of any severity [18].…”

Section: Introductionmentioning

confidence: 99%

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Le¹,

Le

²

,

Phạm

³

et al. 2020

Preprint

0

View full text Add to dashboard Cite

Background: Multidetector computed tomography (MDCT) angiography is an useful examination to detect the source of the bleeding in patients with hemoptysis. The aim of the study was to prospectively evaluate the role and clinical efficacy of MDCT angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence.Methods: It is a double-center study which included 57 hemoptysis patients undergoing MDCT angiography prior to BAE from August 2019 to July 2020. A prospective analysis of culprit arteries detected by MDCT angiography allowed an evaluation of the role of this technique. A follow-up was done to assess the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis.Results: The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 1.73. Among which, the average numbers of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 0.41 and 1.04 1.57, respectively. The immediate clinical success rate, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7%, 18.5%, 16.7%, respectively. Aspergilloma (HR = 6.63, 95% CI: 1.31-33.60, p = 0.022) was associated with an increase in the risk of early recurrence.Conclusions: MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.

show abstract

“…However, the percentage of recurrence following BAE can be high, ranges from 9.8-57.5% in various studies, and increased with time [1]. One of the main reasons is lack of complete exploration of all culprit vessels, particularly ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) [1,4].…”

Section: Introductionmentioning

confidence: 99%

“…To date, there have been many studies reporting that MDCT angiography before BAE plays a critical role in diagnosing both abnormal arteries and underlying lung diseases for hemoptysis [5][6][7][8][9][10][11]. Importantly, it is especially effective to identify origins and courses of ectopic BAs and NBSAs, which should be useful for the management of this disease [4,5,12,13]. However, most reports have been retrospective studies, and the evaluation of e cacy of BAE following MDCT angiography on clinical outcomes is limited.…”

Section: Introductionmentioning

confidence: 99%

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Le¹,

Le²,

Pham³

et al. 2020

Preprint

0

View full text Add to dashboard Cite

Background To prospective evaluate the role and clinical efficacy of multidetector computed tomography (MDCT) angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence.Methods From August 2019 to July 2020, a double-center study of 57 patients with hemoptysis referred for BAE underwent MDCT angiography before. A prospective analysis of culprit arteries detected by MDCT angiography allowed evaluation of the role of this technique. Follow-up was done for assessment of the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis.Results The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 \(\pm\) 1.73, among them the average number of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 \(\pm\) 0.41 and 1.04 \(\pm\) 1.57, respectively. The immediate clinical success, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7%, 18.5%, 16.7%, respectively. Aspergilloma (HR 6.63, 95% CI 1.31–33.60, p = 0.022) was associated with an increase in the risk of early recurrence.Conclusions MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.

show abstract

The Value of 320-Row Multidetector CT Bronchial Arteriography in Recurrent Hemoptysis after Failed Transcatheter Arterial Embolization

Cited by 20 publications

References 30 publications

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Contact Info

Product

Resources

About